China has signaled its intent to cut prices of medicines used to treat serious diseases such as cancer, part of a wider drive to reduce the cost of healthcare for patients in the world’s second-biggest economy.
The National Health and Family Planning Commission is negotiating a pilot program with drug firms to lower the price of five drugs, the official Xinhua news agency reported on Wednesday, citing Li Bin, the head of the commission.
Source: Reuters
Filed Under: Drug Discovery
